Fig. 4From: Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor surveySurvival curves of overall survival and progression-free survival among male patients with deleterious BRCA mutations. Kaplan-Meier curves of OS (a) and PFS (b) between male patients with deleterious BRCAm and those without BRCAm in a 1:3 matched cohort. Kaplan-Meier curves of OS (c) and PFS (d) between male patients with deleterious BRCAm and those with BRCAm of undetermined significance in a 1:1 matched cohort. Propensity score matching for age and TNM stage with a caliper of 0.01 was performed to establish the matched cohortsBack to article page